Dezember 2012 - IOZK

A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report

2012-12-28/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2012-12-28 / J Med Case Rep 2012 Dec;6:427

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

2012-12-27/in Dendritic Cells, Glioblastoma, International Publications /von 2012-12-27 / BMC Cancer 2012 Dec;12:623

Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer

2012-12-17/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-12-17 / Int J Hyperthermia 2013;29(1):8-16

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

2012-12-15/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-12-15 / Cancer Immunol. Immunother. 2013 Apr;62(4):761-72

Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel

2012-12-11/in Breast Cancer, Hyperthermia, International Publications /von 2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-83

Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma

2012-12-01/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2012-12-01 / Clin. Exp. Immunol. 2012 Dec;170(3):291-9

Immunotherapy with tumor vaccines for the treatment of malignant gliomas

2012-12-01/in Glioblastoma, International Publications /von 2012-12-01 / Curr Drug Discov Technol 2012 Dec;9(4):237-55